Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Zipu Jia, Jinyong Yu, Chunmei Zhao, Hao Ren & Fang Luo. (2022) Outcomes and Predictors of Response of Duloxetine for the Treatment of Persistent Idiopathic Dentoalveolar Pain: A Retrospective Multicenter Observational Study. Journal of Pain Research 15, pages 3031-3041.
Read now
Read now
Alessandro Parisi, Maria Vittoria Pensieri, Alessio Cortellini, Carla D’Orazio, Corrado Ficorella, Lucilla Verna & Giampiero Porzio. (2020) Haloperidol for the treatment of opioid addiction in advanced cancer patients: a case series. Journal of Addictive Diseases 38:2, pages 229-234.
Read now
Read now
Hirofumi Tokuoka, Makoto Nishihara, Shinji Fujikoshi, Aki Yoshikawa & Atsushi Kuga. (2017) Predicting treatment outcomes of major depressive disorder by early improvement in painful physical symptoms: a pooled analysis of double-blind, placebo-controlled trials of duloxetine. Neuropsychiatric Disease and Treatment 13, pages 2457-2467.
Read now
Read now
Eiji Harada, Yoichi Satoi, Atsushi Kuga, Hirofumi Tokuoka, Toshiaki Kikuchi, Koichiro Watanabe, Levent Alev & Masaru Mimura. (2017) Associations among depression severity, painful physical symptoms, and social and occupational functioning impairment in patients with major depressive disorder: a 3-month, prospective, observational study. Neuropsychiatric Disease and Treatment 13, pages 2437-2445.
Read now
Read now
Atsushi Kuga, Toshinaga Tsuji, Shinji Hayashi, Mako Matsubara, Shinji Fujikoshi, Hirofumi Tokuoka, Aki Yoshikawa, Rodrigo Escobar, Kazuhide Tanaka & Takaharu Azekawa. (2017) An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis. Neuropsychiatric Disease and Treatment 13, pages 2105-2114.
Read now
Read now
Hiroyuki Enomoto, Shinji Fujikoshi, Jumpei Funai, Nao Sasaki, Michael H Ossipov, Toshinaga Tsuji, Levent Alev & Takahiro Ushida. (2017) Assessment of direct analgesic effect of duloxetine for chronic low back pain: post hoc path analysis of double-blind, placebo-controlled studies. Journal of Pain Research 10, pages 1357-1368.
Read now
Read now
Eiji Harada, Osamu Shirakawa, Yoichi Satoi, Lauren B Marangell & Rodrigo Escobar. (2016) Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder. Neuropsychiatric Disease and Treatment 12, pages 89-97.
Read now
Read now
Diego Novick, William Montgomery, Victoria Moneta, Xiaomei Peng, Roberto Brugnoli & Josep Maria Haro. (2015) Antidepressant medication treatment patterns in Asian patients with major depressive disorder. Patient Preference and Adherence 9, pages 421-428.
Read now
Read now
Stefan Wilhelm, Frank G Boess, Ulrich Hegerl, Roland Mergl, Michael Linden, Alexander Schacht & Edith Schneider. (2012) Tolerability aspects in duloxetine-treated patients with depression: should one use a lower starting dose in clinical practice?. Expert Opinion on Drug Safety 11:5, pages 699-711.
Read now
Read now
Articles from other publishers (23)
Pratap Chokka, Ash Bender, Stefan Brennan, Ghalib Ahmed, Marc Corbière, David J. A. Dozois, Jeff Habert, John Harrison, Martin A. Katzman, Roger S. McIntyre, Yang S. Liu, Karen Nieuwenhuijsen & Carolyn S. Dewa. (2023) Practical pathway for the management of depression in the workplace: a Canadian perspective. Frontiers in Psychiatry 14.
Crossref
Crossref
M.Á. Álvarez-Mon, A. Rodríguez Quiroga, R. Molina-Ruiz & F. Mora. (2023) Mujer de mediana edad con múltiples equivalentes depresivos. Medicine - Programa de Formación Médica Continuada Acreditado 13:84, pages 4989.e1-4989.e3.
Crossref
Crossref
Stefanie Kremer, Teresa Wiesinger, Tom Bschor & Christopher Baethge. (2023) Antidepressants and Social Functioning in Patients with Major Depressive Disorder: Systematic Review and Meta-Analysis of Double-Blind, Placebo-Controlled RCTs. Psychotherapy and Psychosomatics 92:5, pages 304-314.
Crossref
Crossref
Carolin Schneider, Johanna Breilmann, Benedikt Reuter, Thomas Becker & Markus Kösters. (2021) Systematic evaluation of the ‘efficacy‐effectiveness gap’ in the treatment of depression with venlafaxine and duloxetine. Acta Psychiatrica Scandinavica 144:2, pages 113-124.
Crossref
Crossref
Bing Hu. 2021. The Neuroscience of Depression. The Neuroscience of Depression
357
368
.
Daniela Rodrigues-Amorim, José Manuel Olivares, Carlos Spuch & Tania Rivera-Baltanás. (2020) A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine. Frontiers in Psychiatry 11.
Crossref
Crossref
Kyounghoon Park, Seonji Kim, Young-Jin Ko & Byung-Joo Park. (2020) Duloxetine and cardiovascular adverse events: A systematic review and meta-analysis. Journal of Psychiatric Research 124, pages 109-114.
Crossref
Crossref
Fenghua Li, Madeeha Nasir, Baris Olten & Michael H. Bloch. (2020) Meta-analysis of placebo group dropout in adult antidepressant trials. Progress in Neuro-Psychopharmacology and Biological Psychiatry 98, pages 109777.
Crossref
Crossref
Se-Il GoHaa-Na SongSo-Jin LeeEduardo BrueraJung Hun Kang. (2018) Craving Behavior from Opioid Addiction Controlled with Olanzapine in an Advanced Cancer Patient: A Case Report. Journal of Palliative Medicine 21:9, pages 1367-1370.
Crossref
Crossref
Shilpa Telang, Celeste Walton, Baris Olten & Michael H. Bloch. (2018) Meta-analysis: Second generation antidepressants and headache. Journal of Affective Disorders 236, pages 60-68.
Crossref
Crossref
Kiley Cappetta, Chad Beyer, Jessica A. Johnson & Michael H. Bloch. (2018) Meta-analysis: Risk of dry mouth with second generation antidepressants. Progress in Neuro-Psychopharmacology and Biological Psychiatry 84, pages 282-293.
Crossref
Crossref
Roberto Federico Villa, Federica Ferrari & Antonio Moretti. (2018) Post-stroke depression: Mechanisms and pharmacological treatment. Pharmacology & Therapeutics 184, pages 131-144.
Crossref
Crossref
Yena Lee, Joshua D. Rosenblat, JungGoo Lee, Nicole E. Carmona, Mehala Subramaniapillai, Margarita Shekotikhina, Rodrigo B. Mansur, Elisa Brietzke, Jae-Hon Lee, Roger C. Ho, Samantha J. Yim & Roger S. McIntyre. (2018) Efficacy of antidepressants on measures of workplace functioning in major depressive disorder: A systematic review. Journal of Affective Disorders 227, pages 406-415.
Crossref
Crossref
Chad Beyer, Kiley Cappetta, Jessica A. Johnson & Michael H. Bloch. (2017) Meta-analysis: Risk of hyperhidrosis with second-generation antidepressants. Depression and Anxiety 34:12, pages 1134-1146.
Crossref
Crossref
Yohei Shimada, Kazuhide Inage, Sumihisa Orita, Masao Koda, Kazuyo Yamauchi, Takeo Furuya, Junichi Nakamura, Miyako Suzuki, Kazuki Fujimoto, Yasuhiro Shiga, Koki Abe, Hirohito Kanamoto, Masahiro Inoue, Hideyuki Kinoshita, Masaki Norimoto, Tomotaka Umimura, Kazuhisa Takahashi & Seiji Ohtori. (2017) Effect of duloxetine on neuropathic pain in patients intolerant to continuous administration of pregabalin. Spine Surgery and Related Research 1:1, pages 40-43.
Crossref
Crossref
Stefan GebhardtMonika Heinzel-GutenbrunnerUdo König. (2016) Pain Relief in Depressive Disorders. Journal of Clinical Psychopharmacology 36:6, pages 658-668.
Crossref
Crossref
Vanessa C. Evans, Golnoush Alamian, Jane McLeod, Cindy Woo, Lakshmi N. Yatham & Raymond W. Lam. (2016) The Effects of Newer Antidepressants on Occupational Impairment in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. CNS Drugs 30:5, pages 405-417.
Crossref
Crossref
Jihyung Hong, Diego Novick, William Montgomery, Maria Victoria Moneta, Héctor Dueñas, Xiaomei Peng & Josep Maria Haro. (2015)
Real‐world outcomes in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in
E
ast
A
sia
. Asia-Pacific Psychiatry 8:1, pages 51-59.
Crossref
Crossref
Eiji Harada, Hirofumi Tokuoka, Shinji Fujikoshi, Jumpei Funai, Madelaine M. Wohlreich, Michael H. Ossipov & Nakao Iwata. (2016) Is duloxetine's effect on painful physical symptoms in depression an indirect result of improvement of depressive symptoms? Pooled analyses of three randomized controlled trials. Pain 157:3, pages 577-584.
Crossref
Crossref
David V. Sheehan, Michele Mancini, Jianing Wang, Lovisa Berggren, Haijun Cao, Héctor José Dueñas & Li Yue. (2015) Assessment of functional outcomes by Sheehan Disability Scale in patients with major depressive disorder treated with duloxetine versus selective serotonin reuptake inhibitors. Human Psychopharmacology: Clinical and Experimental 31:1, pages 53-63.
Crossref
Crossref
Michael PT Lunn, Richard AC Hughes & Philip J Wiffen. (2014) Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database of Systematic Reviews 2015:10.
Crossref
Crossref
Lana J. Williams, Julie A. Pasco, Felice N. Jacka, Seetal Dodd & Michael Berk. (2012) Pain and the relationship with mood and anxiety disorders and psychological symptoms. Journal of Psychosomatic Research 72:6, pages 452-456.
Crossref
Crossref
Michael Happich, Edith Schneider, Stefan Wilhelm, Thomas Zimmermann & Alexander Schacht. (2012) Depression Treatment with Duloxetine and Reduction of Inability to Work. Depression Research and Treatment 2012, pages 1-6.
Crossref
Crossref